Intrinsic Value of S&P & Nasdaq Contact Us

Repligen Corporation RGEN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
61/100
1/7 Pass
SharesGrow Intrinsic Value
$186.82
+42.6%
Analyst Price Target
$183.00
+39.7%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Repligen Corporation (RGEN) has shown declining revenue growth over the past 3 years, expanding from $802M to $738M (average -1.5%/yr). Net income reached $49M, reflecting solid earnings growth at +13%/yr on average. The net profit margin is 6.6%, which is moderate. the company was profitable in 3 out of the last 4 years tracked. The gross margin is 47.1% (moderate), with a -9.8pp trend over the period. With a $7B market cap and MOAT composite score of 48/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (48/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (75/100, Partial) — profitability has been inconsistent. Looking at the full 40-year history, the company was profitable in 17 of 40 years — a mixed long-term record
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (48/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 61/100 with 1/7 criteria passed.

61/100
SG Score
View full scorecard →
~
VALUE
49/100
Price-to-Earnings & upside
→ IV page
FUTURE
94/100
Analyst consensus
→ Forecast
~
PAST
75/100
3/4 yrs profit
EPS $0.86
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
48/100
Score: 48/100
GM 47.1% (-9.8pp)
Proven by this page
~
GROWTH
48/100
Rev -1.5%/yr
NI +13%/yr
Proven by this page
~
INCOME
45/100
Margin 6.6%
$738M
Proven by this page
Repligen Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $738.26M$738.26M$634.44M$632.36M$801.54M
Gross Profit $375.86M$347.62M$274.65M$308.83M$455.71M
Gross Margin 50.9%47.1%43.3%48.8%56.9%
Operating Income $55.86M$59.58M$-35.11M$47.7M$133.61M
Net Income $48.89M$48.89M$-25.51M$35.6M$185.96M
Net Margin 6.6%6.6%-4%5.6%23.2%
EPS (Diluted) $0.85$0.86$-0.46$0.63$3.24
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message